KLRK1 and breast cancer: However, CSCs from acute myeloid leukemia (AML) [36], GBM [27] and breast cancer (BC) [37] were shown to induce T cell polarization toward Th2 phenotype [27], and to escape NK cell-mediated killing by the downregulation of activating NKG2D ligands.